On improving research methodology in clinical trials

被引:10
作者
Berger, Vance W. [1 ]
Matthews, J. Rosser [2 ]
Grosch, Eric N. [3 ]
机构
[1] Univ Maryland, NCI, Baltimore, MD 21201 USA
[2] Georgetown Univ, Washington, DC USA
[3] United Urgent Care Clin, Ft Myers, FL USA
关键词
D O I
10.1177/0962280207080639
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Research plays a vital role within biomedicine. Scientifically appropriate research provides a basis for appropriate medical decisions; conversely, inappropriate research may lead to flawed 'best medical practices' which, when followed, contribute to avoidable morbidity and mortality. Although an all-encompassing definition of 'appropriate medical research' is beyond the scope of this article, the concept clearly entails (among other things) that research methods be continually revised and updated as better methods become available. Despite the advent of evidence-based medicine, many research methods have become 'standard' even though there are legitimate scientific reasons to question the conclusions reached by such methods. We first illustrate prominent examples of inappropriate (yet regimented) research methods that are in widespread use. Second, as a way to improve the situation, we suggest a model of research that relies on standardized statistical analyses that individual researchers must consider as a default, but are free to challenge when they can marshal sufficient scientific evidence to demonstrate that the challenge is warranted. Third, we characterize the current system as analogous to 'unnatural selection' in the biological world and argue that our proposed model of research will enable 'natural' to replace 'unnatural' selection in the choice of research methodologies. Given the pervasiveness of inappropriate research methods, we believe that there are strong scientific and ethical reasons to create such a system, that, if properly designed, will both facilitate creativity and ensure methodological rigor while protecting the public at large from the threats posed by poor medical treatment decisions resulting from flawed research methodology.
引用
收藏
页码:231 / 242
页数:12
相关论文
共 23 条
[1]   Poor-quality medical research - What can journals do? [J].
Altman, DG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (21) :2765-2767
[2]   The revised CONSORT statement for reporting randomized trials: Explanation and elaboration [J].
Altman, DG ;
Schulz, KF ;
Moher, D ;
Egger, M ;
Davidoff, F ;
Elbourne, D ;
Gotzsche, PC ;
Lang, T .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (08) :663-694
[3]   Analysis of trichotomous pharmaceutical endpoints [J].
Berger, VW ;
Durkalski, VL .
JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2005, 15 (04) :739-745
[4]   The reverse propensity score to detect selection bias and correct for baseline imbalances [J].
Berger, VW .
STATISTICS IN MEDICINE, 2005, 24 (18) :2777-2787
[5]  
Berger VW, 2005, MED J AUSTRALIA, V183, P165, DOI 10.5694/j.1326-5377.2005.tb06974.x
[6]   On the generation and ownership of alpha in medical studies [J].
Berger, VW .
CONTROLLED CLINICAL TRIALS, 2004, 25 (06) :613-619
[7]  
Berger VW, 2005, STAT PRACT, P1, DOI 10.1002/0470863641
[8]   Minimizing predictability while retaining balance through the use of less restrictive randomization procedures [J].
Berger, VW ;
Ivanova, A ;
Knoll, MD .
STATISTICS IN MEDICINE, 2003, 22 (19) :3017-3028
[9]   Direct effect on validity of response run-in selection in clinical trials [J].
Berger, VW ;
Rezvani, A ;
Makarewicz, VA .
CONTROLLED CLINICAL TRIALS, 2003, 24 (02) :156-166
[10]   Detecting selection bias in randomized clinical trials [J].
Berger, VW ;
Exner, DV .
CONTROLLED CLINICAL TRIALS, 1999, 20 (04) :319-327